News

Portsmouth Square Enhances Financial Flexibility with Refinancing

Portsmouth Square Enhances Financial Flexibility with Refinancing

Portsmouth Square's Strategic Move for Financial Growth

Portsmouth Square, Inc. has taken a bold step towards ensuring its financial strength by successfully refinancing its key asset—the Hilton San Francisco Financial District Hotel. This strategic refinancing is not just a financial maneuver; it marks a new chapter of flexibility and stability for the company.

Refinancing Details and Future Outlook

The refinancing initiative was spearheaded through Justice Operating Company, LLC, a fully owned subsidiary of Portsmouth Square. They successfully secured a substantial mortgage loan of $67 million, thanks to the expert arrangement by Eastdil Secured, LLC, a prominent player in global real estate investment banking. The agreement sets a floating interest rate pegged to the 30-day Secured Overnight Financing Rate (SOFR) plus an additional 4.80%, offering a balanced approach to interest rate management. To mitigate risks associated with rate fluctuations, the company has proactively obtained an interest rate cap that limits SOFR exposure to a maximum of 4.50%.

A Flexible Financial Framework

Complementing this effort, another subsidiary, Justice Mezzanine Company, LLC, has also restructured its existing mezzanine loan with CRED REIT Holdco LLC, now standing at a fixed principal amount of $36.3 million with an attractive interest rate of 7.25% per annum. Both loans have a maturity period of two years, with options to extend for three additional one-year periods, granting Portsmouth Square the flexibility to adapt and grow based on market conditions.

Leadership's Vision Forward

David Gonzalez, the President of Portsmouth Square, expressed his optimism regarding this refinancing deal. He stated that "this refinancing is a significant step in our strategic financial management, ensuring favorable terms and financial stability." His remarks underscore the company's dedication to prudent financial practices while positioning itself favorably for future growth and sustained value creation.

Continued Commitment to Transparency

The comprehensive details surrounding these refinancing transactions will be disclosed in the company’s periodic reports to the Securities and Exchange Commission (SEC). This move reflects Portsmouth Square's commitment to maintaining transparency and building trust with its stakeholders.

About Portsmouth Square, Inc.

Founded in 1967, Portsmouth Square, Inc. is a recognized California corporation. The company stands out as a public entity under the umbrella of The InterGroup Corporation, which trades on NASDAQ under the ticker INTG. The primary operations of Portsmouth Square focus on the ownership of its flagship asset: the Hilton San Francisco Financial District, a notable 544-room hotel, which includes a highly functional five-level underground parking garage, enhancing the overall value of the property.

Contact Information:
David Gonzalez, President
(310)889-2559

Frequently Asked Questions

What is the significance of the refinancing for Portsmouth Square?

This refinancing enhances Portsmouth Square's financial flexibility and stability, positioning it for future growth.

How much did Portsmouth Square secure in the refinancing?

Portsmouth Square secured a total of $67 million in a mortgage loan and $36.3 million in a modified mezzanine loan.

Who arranged the mortgage loan for Portsmouth Square?

The mortgage loan was arranged by Eastdil Secured, LLC, a leading real estate investment banking firm.

What is the maturity period of the loans?

Both loans have a maturity period of two years, with options to extend for three additional one-year periods.

What is the primary business of Portsmouth Square?

Portsmouth Square primarily conducts its business through the ownership of the Hilton San Francisco Financial District hotel.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 20

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 13

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 15

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 14

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 14

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 14

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 14

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

FDA's NMN Ruling: Naturecan Seizes Opportunities for Growth

Updated Category News Views 158

FDA's NMN Ruling and Its Significance Naturecan, a prominent global wellness brand, is thrilled by the recent ruling from the U.S. Food and Drug Administration (FDA) regarding ?-Nicotinamide Mononucleotide (NMN). This ruling confirms that NMN is lawful for use in dietary supplements in the United States, paving the way for significant advancements within the global...

Continue Reading
Casepoint Secures Major SEC Contract for Innovative Data Solutions

Updated Category News Views 184

Casepoint Secures Important Contract Extension with the SEC Casepoint, a leading company in data discovery technology, has successfully extended its contract with the U.S. Securities and Exchange Commission (SEC). This five-year agreement highlights Casepoint's dedication to providing secure, cloud-based solutions designed for regulatory enforcement and compliance in a...

Continue Reading
Intel Corp's Future with Apple: Chip Manufacturing Wins

Updated Category News Views 359

Intel Corp's Significant Stock Surge Intel Corp (NASDAQ: INTC) saw its stock rise by 7%, thanks to a report signaling the company's exciting potential to produce chips for Apple Inc's upcoming Mac models. Industry analyst Ming-Chi Kuo from TF International Securities provided an optimistic outlook, suggesting Intel is gaining traction in its efforts to expand operations....

Continue Reading
Significant Phase II Breakthrough for Akeso's Ivonescimab in NSCLC

Updated Category News Views 195

Akeso's Promising Results with Ivonescimab for Lung Cancer Akeso (9926.HK) has recently shared exciting findings from the Phase II study of ivonescimab, a groundbreaking PD-1/VEGF bispecific antibody designed to treat resectable non-small cell lung cancer (NSCLC). This study was highlighted during a key oral session at the 25th World Conference on Lung Cancer (WCLC),...

Continue Reading
Insider Trades at Sherwin-Williams: A Closer Look at Rea's Moves

Updated Category News Views 204

Recent Insider Trading Activity at Sherwin-Williams Todd Rea, who holds the position of President at Sherwin-Williams (NYSE: SHW), has recently become the center of attention due to his stock option activities. The latest SEC filing reveals that he made a notable decision by exercising options for zero shares of the company’s stock. What This Means for Investors In the...

Continue Reading